Caryn Gee Morse, MD, MPH

About Me

Education: BA, University of Virginia, 1994; MD, University of Virginia School of Medicine, 1998; MPH, University of North Carolina at Chapel Hill, 2005
Residency: Internal Medicine, North Carolina Baptist Hospital, 2001
Fellowship: Infectious Disease, Wake Forest Baptist Medical Center, 2003
Board Certifications: American Board of Internal Medicine, Infectious Disease
Positions: Associate Professor, Infectious Diseases
Departments and Affiliations: Infectious Diseases

Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease. Sinkus R, Lambert S, Abd-Elmoniem KZ, Morse C, Heller T, Guenthner C, Ghanem AM, Holm S, Gharib AM. NMR Biomed. 2018 10; 31(10):e3956.
Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease. Chaudhury CS, Purdy JB, Liu CY, Morse CG, Stanley TL, Kleiner D, Hadigan C. Liver Int. 2018 05; 38(5):797-802.
Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score. Mee TC, Aepfelbacher J, Krakora R, Chairez C, Kvaratskhelia N, Smith B, Sandfort V, Hadigan C, Morse C, Hammoud DA. Antivir. Ther. (Lond.). 2018; 23(8):695-698.
Fatty liver disease in HIV: common, underappreciated, and understudied. Morse CG. AIDS. 2017 07; 31(11):1633-1635.
Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes. Burbelo PD, Gunti S, Keller JM, Morse CG, Deeks SG, Lionakis MS, Kapoor A, Li Q, Cohen JI, Notkins AL, Alevizos I. Sci Rep. 2017 06; 7(1):3818.

View More Publications